NCT04271228View on ClinicalTrials.gov

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

January 19, 2022

Study Completion Date

January 19, 2022

Conditions
Type 1 Diabetes
Interventions
DEVICE

DreaMed Advisor Pro

Using the DreaMed Advisor Pro as an advisory tool for Health Care Professionals during routine clinical use

Trial Locations (1)

4920235

Schnider Children's Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT04271228 - Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1 | Biotech Hunter | Biotech Hunter